Cargando…
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis
In the end of 2019 COVID-19 emerged as a new threat worldwide and this disease present impaired immune system, exacerbated production of inflammatory cytokines, and coagulation disturbs. Mesenchymal stem cell (MSC) derived extracellular vesicles (EVs) have emerged as a therapeutic option due to its...
Autores principales: | Schultz, Iago Carvalho, Bertoni, Ana Paula Santin, Wink, Márcia Rosângela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842178/ https://www.ncbi.nlm.nih.gov/pubmed/33511519 http://dx.doi.org/10.1007/s12015-021-10122-0 |
Ejemplares similares
-
MSC-Exosomes Carrying miRNA – Could they Enhance Tocilizumab Activity in Neuropathology of COVID-19?
por: Schultz, Iago C., et al.
Publicado: (2022) -
Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma
por: Grange, Cristina, et al.
Publicado: (2019) -
SVF-derived extracellular vesicles carry characteristic miRNAs in lipedema
por: Priglinger, Eleni, et al.
Publicado: (2020) -
NTPDase5/PCPH as a New Target in Highly Aggressive Tumors: A Systematic Review
por: Bracco, Paula Andreghetto, et al.
Publicado: (2014) -
Purinergic signaling elements are correlated with coagulation players in peripheral blood and leukocyte samples from COVID-19 patients
por: Schultz, Iago C., et al.
Publicado: (2022)